# Ice Neurosystems, Inc.

- Location (FDA's records): Washington, DC
- FDA decisions: 3 (2020–2022): 3 510(k) clearances
- Product codes: GZL (2), GWQ (1)
- 510(k) review time since 2016: median 262 days, against 216 for FDA's reviews in the same codes and years (0 of 3 faster)
- Predicates its devices cite: 5 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Moberg Research, Inc.: 1 (https://510kreport.com/company/moberg-research)
- Persyst Development Corporation: 1 (https://510kreport.com/company/persyst-development)
- Ad-Tech Medical Instrument Corp: 1 (https://510kreport.com/company/ad-tech-medical-instrument)
- Radionics, Inc.: 1 (https://510kreport.com/company/radionics)

## Its most-cited devices
- K201678: iCE-SG Subcutaneous Electrode Arrays (2021), cited by 1

## Recent decisions
- K222706: iCE-SG2 Subcutaneous Electrode Kit (Dec 6, 2022)
- K201678: iCE-SG Subcutaneous Electrode Arrays (Mar 8, 2021)
- K191868: iCEWav Neuromonitoring Platform (Mar 31, 2020)

Source page: https://510kreport.com/company/ice-neurosystems